Appendix (Business Analysis Project) : View: Annual Data

Appendix ( Business Analysis Project)
Balance sheet of Procter & Gamble Company.

View: Annual data
PERIOD ENDING
All numbers in thousands
06/2010
06/2009
06/2008
06/2007
Cash and Equivalents
2,879,000
4,781,000
3,313,000
5,354,000
Marketable Securities
228,000
202,000
Accounts Receivable
5,335,000
5,836,000
6,761,000
6,629,000
Receivables
5,335,000
5,836,000
6,761,000
6,629,000
Raw Materials
1,692,000
1,557,000
2,262,000
1,590,000
604,000
672,000
765,000
444,000
Finished Goods
4,088,000
4,651,000
5,389,000
4,785,000
Inventories
6,384,000
6,880,000
8,416,000
6,819,000
Prepaid Expenses
3,194,000
3,199,000
3,785,000
3,300,000
990,000
1,209,000
2,012,000
1,727,000
Total Current Assets
18,782,000
21,905,000
24,515,000
24,031,000
Land & Improvements
850,000
885,000
889,000
849,000
6,868,000
6,724,000
7,052,000
6,380,000
Machinery, Furniture & Equipment
29,294,000
29,042,000
30,145,000
27,492,000
Total Fixed Assets
37,012,000
36,651,000
38,086,000
34,721,000
Gross Fixed Assets (Plant, Prop. &

Equip.)
37,012,000
36,651,000
38,086,000
34,721,000
Accumulated Depreciation & Depletion
17,768,000
17,189,000
17,446,000
15,181,000
Net Fixed Assets (Net PP&E)
19,244,000
19,462,000
20,640,000
19,540,000
Intangibles
31,636,000
32,606,000
34,233,000
33,626,000
Cost in Excess
54,012,000
56,512,000
59,767,000
56,552,000
Other Non-Current Assets
4,498,000
4,348,000
4,837,000
4,265,000
Total Non-Current Assets
109,390,000
112,928,000
119,477,000
113,983,000
Total Assets
128,172,000
134,833,000
143,992,000
138,014,000
Balance Sheet - Assets
Work in Progress
Current Deferred Income Taxes
Building & Improvements
Balance Sheet - Liabilities, Stockholders Equity

Accounts Payable
7,251,000
5,980,000
6,775,000
5,710,000
Short Term Debt
8,472,000
16,320,000
13,084,000
12,039,000
Accrued Liabilities
8,559,000
8,601,000
10,154,000
608,000
Other Current Liabilities
945,000
12,360,000
Total Current Liabilities
24,282,000
30,901,000
30,958,000
30,717,000
Long Term Debt
21,360,000
20,652,000
23,581,000
23,375,000
Deferred Income Taxes
10,902,000
10,752,000
11,805,000
12,015,000
Other Non-Current Liabilities
10,189,000
9,429,000
8,154,000
5,147,000
324,000
Total Non-Current Liabilities
42,775,000
40,833,000
43,540,000
40,537,000
Total Liabilities
67,057,000
71,734,000
74,498,000
71,254,000
Preferred Stock Equity
1,277,000
1,324,000
1,366,000
1,406,000
Common Stock Equity
59,838,000
61,775,000
68,128,000
65,354,000
4,008,000
4,007,000
4,002,000
Additional Paid In Capital
61,697,000
61,118,000
60,307,000
63,020,000
Retained Earnings
64,614,000
57,309,000
48,986,000
41,797,000
(61,309,000)
(55,961,000)
(47,588,000)
(38,772,000)
Other Equity Adjustments
(9,172,000)
(4,698,000)
2,421,000
(691,000)
Total Capitalization
82,475,000
83,751,000
93,075,000
90,135,000
Total Equity
61,115,000
63,099,000
69,494,000
66,760,000
128,172,000
134,833,000
143,992,000
138,014,000
Cash Flow
15,625,000
16,326,000
15,065,000
13,309,000
Working Capital
(5,500,000)
(8,996,000)
(6,443,000)
(6,686,000)
Free Cash Flow
7,122,000
6,269,000
7,732,000
5,789,000
Invested Capital
82,475,000
83,751,000
93,075,000
90,135,000
Minority Interest
Common Par
Treasury Stock
Total Liabilities & Stock Equity
Balance sheet of Unilever company:

View: Annual Data
PERIOD ENDING
12/2010
12/2009
12/2008
12/2007
3,107,014
3,790,585
3,574,000
1,603,000
737,848
1,394,568
882,000
313,000
Accounts Receivable
5,547,282
3,319,990
3,890,000
4,330,000
Loans Receivable
3,000
Other Receivable
922,538
1,241,000
1,113,000
5,547,282
4,242,528
5,131,000
5,446,000
Raw Materials
1,862,293
2,005,000
2,053,000
Finished Goods
3,271,209
3,422,000
3,633,000
Other Inventories
5,780,711
Inventories
5,780,711
5,133,502
5,427,000
5,686,000
677,197
530,000
682,000
399,779
248,210
Other Current Assets
1,175,192
24,390
50,000
768,000
16,747,830
15,510,982
15,594,000
14,498,000
Land & Improvements
4,644,256
3,963,000
4,409,000
Receivables
Prepaid Expenses
14,932,782
13,283,000
14,974,000
Other Fixed Assets
10,536,483
Total Fixed Assets
10,536,483
19,577,038
17,246,000
19,383,000
Gross Fixed Assets (Plant, Prop. & Equip.)
10,536,483
19,577,038
17,245,000
19,383,000
10,044,620
8,933,000
10,206,000
10,536,483
9,532,417
8,312,000
9,177,000
Intangibles
24,520,733
6,575,417
6,176,000
6,587,000
17,882,609
16,277,000
17,880,000
814,316
1,058,838
1,490,000
1,465,000
2,607,960
2,548,099
2,583,000
4,866,000
38,479,494
37,597,383
34,838,000
39,975,000
Total Assets
55,227,324
53,108,365
50,433,000
54,472,000
13,718,624
12,070,474
5,404,000
5,389,000
3,053,353
3,269,774
6,757,000
5,972,000
3,795,000
4,337,000
1,481,064
1,301,309
3,300,000
4,103,000
18,253,041
16,641,558
19,257,000
19,800,000
9,736,923
11,036,026
8,451,000
8,007,000
255,000
1,180,558
1,096,141
1,102,000
1,771,000
5,829,006
6,348,728
6,722,000
6,174,000
795,535
675,762
592,000
631,000
173,000
17,542,023
19,156,659
17,295,000
16,583,000
Total Liabilities
35,795,065
35,798,218
36,551,000
36,384,000
Common Stock Equity
19,432,258
17,310,147
13,881,000
18,089,000
Common Par
649,307
694,414
Additional Paid In Capital
179,766
187,951
844,000
930,000
(2,362,000)
(146,000)
18,603,184
16,427,782
22,064,000
22,141,000
Treasury Stock
(6,385,000)
(4,804,000)
(279,000)
(32,000)
29,169,182
28,346,174
22,332,000
26,096,000
Total Equity
19,432,258
17,310,147
13,881,000
18,089,000
55,227,324
53,108,365
50,432,000
54,473,000
5,693,510
6,730,369
8,415,000
7,055,000
Working Capital
(1,505,211)
(1,130,575)
(3,662,000)
(5,303,000)
Free Cash Flow
819,683
2,357,279
3,853,000
(131,000)
Invested Capital
29,169,182
28,346,174
22,587,000
26,096,000
Cost in Excess
Non-Current Deferred Income Taxes

Accounts Payable
Short Term Debt
Accrued Liabilities
Long Term Debt

Capital Lease Obligations
Minority Interest
Preferred Equity outside Stock Equity
Cumulative Translation Adjustment

Retained Earnings
Cash Flow
Balance sheet of Johnson & Johnson company:

View: Annual Data | Quarterly Data
PERIOD ENDING
12/2010
12/2009
12/2008
12/2007
19,355,000
15,810,000
10,768,000
7,770,000
8,303,000
3,615,000
2,041,000
1,545,000
Accounts Receivable
9,774,000
9,646,000
9,719,000
9,444,000
Receivables
9,774,000
9,646,000
9,719,000
9,444,000
Raw Materials
1,073,000
1,144,000
839,000
905,000
Work in Progress
1,460,000
1,395,000
1,372,000
1,384,000
Finished Goods
2,845,000
2,641,000
2,841,000
2,821,000
Inventories
5,378,000
5,180,000
5,052,000
5,110,000
Prepaid Expenses
2,273,000
2,497,000
3,367,000
3,467,000
2,224,000
2,793,000
3,430,000
2,609,000
47,307,000
39,541,000
34,377,000
29,945,000
Land & Improvements
738,000
714,000
886,000
756,000
9,079,000
8,863,000
7,720,000
7,913,000
18,032,000
17,153,000
15,234,000
14,554,000
2,577,000
2,521,000
3,552,000
3,243,000
Total Fixed Assets
30,426,000
29,251,000
27,392,000
26,466,000
Gross Fixed Assets (Plant, Prop. &

Equip.)
30,426,000
29,251,000
27,392,000
26,466,000
15,873,000
14,492,000
13,027,000
12,281,000
14,553,000
14,759,000
14,365,000
14,185,000
Intangibles
16,716,000
16,323,000
13,976,000
14,640,000
Cost in Excess
15,294,000
14,862,000
13,719,000
14,123,000
Non-Current Deferred Income Taxes
5,096,000
5,507,000
5,841,000
4,889,000
3,942,000
3,690,000
2,634,000
3,172,000
55,601,000
55,141,000
50,535,000
51,009,000
102,908,000
94,682,000
84,912,000
80,954,000
Building & Improvements

Construction in Progress
Total Assets

Accounts Payable
5,623,000
5,541,000
7,503,000
6,909,000
Notes Payable
7,617,000
6,318,000
3,732,000
2,463,000
9,254,000
9,430,000
9,200,000
10,465,000
578,000
442,000
417,000
23,072,000
21,731,000
20,852,000
19,837,000
Long Term Debt
9,156,000
8,223,000
8,120,000
7,074,000
1,447,000
1,424,000
1,432,000
1,493,000
Short Term Debt

Accrued Liabilities
12,654,000
12,716,000
11,997,000
9,231,000
23,257,000
22,363,000
21,549,000
17,798,000
Total Liabilities
46,329,000
44,094,000
42,401,000
37,635,000
Common Stock Equity
56,579,000
50,588,000
42,511,000
43,319,000
3,120,000
3,120,000
3,120,000
3,120,000
628,000
77,773,000
70,306,000
63,379,000
55,280,000
(20,783,000)
(19,780,000)
(19,033,000)
(14,388,000)
(3,531,000)
(3,058,000)
(4,955,000)
(1,321,000)
65,735,000
58,811,000
50,631,000
50,393,000
Total Equity
56,579,000
50,588,000
42,511,000
43,319,000
102,908,000
94,682,000
84,912,000
80,954,000
Cash Flow
16,273,000
15,040,000
15,781,000
13,353,000
Working Capital
24,235,000
17,810,000
13,525,000
10,108,000
Free Cash Flow
6,928,000
6,409,000
5,668,000
5,881,000
Invested Capital
65,735,000
58,811,000
50,631,000
50,393,000
Common Par
Cumulative Translation Adjustment
Retained Earnings
Treasury Stock
Cash flow statement of Johnson and Johnson company

View: Annual Data
PERIOD ENDING
12/2010
12/2009
12/2008
12/2007
13,334,000
12,266,000
12,949,000
10,576,000
2,939,000
2,774,000
2,832,000
2,777,000
356,000
(436,000)
22,000
(1,762,000)
181,000
807,000
(Increase) Decrease in Receivables
(207,000)
453,000
(736,000)
(416,000)
(Increase) Decrease in Inventories
(196,000)
95,000
(101,000)
14,000
20,000
(507,000)
(272,000)
2,642,000
(487,000)
1,240,000
(616,000)
(787,000)
626,000
686,000
713,000
1,398,000
Net Cash from Continuing Operations
16,385,000
16,571,000
14,972,000
15,249,000
Net Cash from Operating Activities
16,385,000
16,571,000
14,972,000
15,249,000
230,000
Sale of Long Term Investments
11,101,000
7,232,000
3,059,000
Sale of Short Term Investments
7,988,000
Purchase of Property, Plant, Equipment
(2,384,000)
(2,365,000)
(3,066,000)
(3,310,000)
Acquisitions
(1,269,000)
(2,470,000)
(1,214,000)
(1,388,000)
(15,788,000)
(10,040,000)
(3,668,000)
Cash Flow From Operating Activities

Net Income (Loss)
Depreciation
Operating (Gains) Losses
(Increase) Decrease in Payables

(Increase) Decrease in Other Working
Capital
Other Non-Cash Items
Sale of Property, Plant, Equipment
Purchase of Long Term Investments
Purchase of Short Term Investments
(9,659,000)
486,000
45,000
702,000
(7,854,000)
(7,598,000)
(4,187,000)
(6,139,000)
Issuance of Debt
8,992,000
9,493,000
10,068,000
24,726,000
Issuance of Capital Stock
1,226,000
882,000
1,486,000
1,562,000
Repayment of Debt
(6,597,000)
(7,010,000)
(7,343,000)
(21,709,000)
Repurchase of Capital Stock
(2,797,000)
(2,130,000)
(6,651,000)
(5,607,000)
Payment of Cash Dividends
(5,804,000)
(5,327,000)
(5,024,000)
(4,670,000)
Net Cash from Financing Activities
(4,980,000)
(4,092,000)
(7,464,000)
(5,698,000)
(6,000)
161,000
(323,000)
275,000
3,545,000
5,042,000
2,998,000
3,687,000
Cash at Beginning of Period
15,810,000
10,768,000
7,770,000
4,083,000
Cash at End of Period
19,355,000
15,810,000
10,768,000
7,770,000
Foreign Sales
32,137,000
31,008,000
31,438,000
28,651,000
Domestic Sales
29,450,000
30,889,000
32,309,000
32,444,000
UQ
UQ
UQ
UQ
Other Investing Changes Net

Net Cash from Investing Activities
Effect of Exchange Rate Changes

Net Change in Cash & Cash Equivalents
Auditor's Report (Aud. Name & Aud. Op.)
Cash flow statement of Procter & Gamble company:

View: Annual Data
PERIOD ENDING
06/2010
06/2009
06/2008
06/2007
12,736,000
13,436,000
12,075,000
10,340,000
3,108,000
3,082,000
3,166,000
3,130,000
36,000
596,000
1,214,000
253,000
(2,670,000)
(2,377,000)
527,000
592,000
(14,000)
415,000
432,000
(729,000)
86,000
721,000
(1,050,000)
(389,000)
2,446,000
(742,000)
134,000
(273,000)
(Increase) Decrease in Other Working

Capital
(305,000)
(758,000)
(1,239,000)
(157,000)
649,000
546,000
555,000
668,000
16,072,000
14,919,000
15,814,000
13,435,000
16,072,000
14,919,000
15,814,000
13,435,000
3,068,000
928,000
281,000
166,000
673,000
(3,067,000)
(3,238,000)
(3,046,000)
(2,945,000)
(425,000)
(368,000)
(381,000)
(492,000)
(50,000)

Net Income (Loss)
Depreciation

Acquisitions
Purchase of Short Term Investments
(173,000)
1,087,000
(597,000)
(2,353,000)
(2,549,000)
(2,483,000)
Issuance of Debt
3,830,000
4,926,000
13,739,000
721,000
681,000
1,867,000
1,499,000
(10,344,000)
(5,007,000)
(17,929,000)
(6,004,000)
(6,370,000)
(10,047,000)
(5,578,000)
(5,458,000)
(5,044,000)
(4,655,000)
(4,209,000)
(2,815,000)
(17,255,000)
(10,814,000)
(15,650,000)
(12,478,000)
(122,000)
(284,000)
344,000
187,000
(1,902,000)
1,468,000
(2,041,000)
(1,339,000)
4,781,000
3,313,000
5,354,000
6,693,000
2,879,000
4,781,000
3,313,000
5,354,000
Foreign Sales
45,784,040
47,949,000
50,498,000
44,530,000
Domestic Sales
33,153,960
31,080,000
33,005,000
31,946,000
UQ
UQ
UQ
UQ

Repayment of Debt
Other Financing Charges, Net

Cash flow statement of unilever company:

View: Annual Data |
PERIOD ENDING
12/2010
12/2009
12/2008
12/2007
Net Income (Loss)
5,249,716
7,375,000
6,040,000
Depreciation
1,480,652
1,400,000
1,377,000
(1,307,048)
(2,556,000)
(837,000)
918,234
(346,000)
(63,000)
678,632
(481,000)
(486,000)
843,627
603,000
589,000
7,365,074
420,379
(592,000)
(959,000)
7,365,074
8,284,193
5,402,000
5,660,000
7,365,074
8,284,193
5,402,000
5,660,000
159,256
265,000
238,000
321,381
66,000
48,000
127,000
(2,281,965)
(1,964,160)
(1,799,000)
(1,726,000)
(484,297)
(199,428)
3,161,000
(73,000)
(136,300)
(176,000)
(73,000)
1,204,706
7,173
331,000
676,000
(1,561,556)
(1,812,077)
1,974,000
(910,000)
4,179,399
6,341,000
6,291,000

Acquisitions
Purchase of Long Term Investments
Issuance of Debt
147,778
144,000
645,000
Repayment of Debt
(6,427,638)
(4,876,000)
(4,337,000)
(2,097,000)
(2,190,000)
(3,779,128)
(3,763,325)
(2,911,000)
(3,992,000)
Other Financing Charges, Net
(2,404,046)
(307,034)
(968,000)
(810,000)
(6,183,174)
(6,170,820)
(4,368,000)
(4,394,000)
(198,548)
(248,210)
(973,000)
(77,000)
(578,205)
53,085
2,036,000
279,000
3,215,679
3,385,988
1,257,000
1,037,000
2,637,474
3,439,073
3,293,000
1,316,000
54,697,414
52,280,520
4,681,987
4,855,162
UQ
UQ
UQ
UQ
Foreign Sales
Domestic Sales
Source:
http://finapps.forbes.com/finapps/jsp/finance/compinfo/CashFlows.jsp?tkr=un
www.forbes.com

Appendix (Business Analysis Project) : View: Annual Data

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Appendix (Business Analysis Project) : View: Annual Data

Uploaded by

Copyright:

Available Formats

Appendix ( Business Analysis Project)

Balance sheet of Procter & Gamble Company.

All numbers in thousands

Cash and Equivalents

Total Current Assets

Land & Improvements

Machinery, Furniture & Equipment

Total Fixed Assets

Gross Fixed Assets (Plant, Prop. &

Accumulated Depreciation & Depletion

Net Fixed Assets (Net PP&E)

Other Non-Current Assets

Total Non-Current Assets

Balance Sheet - Assets

Current Deferred Income Taxes

Building & Improvements

Balance Sheet - Liabilities, Stockholders Equity

Short Term Debt

Other Current Liabilities

Total Current Liabilities

Long Term Debt

Deferred Income Taxes

Other Non-Current Liabilities

Total Non-Current Liabilities

Preferred Stock Equity

Common Stock Equity

Additional Paid In Capital

Other Equity Adjustments

Free Cash Flow

Total Liabilities & Stock Equity

Balance sheet of Unilever company:

All numbers in thousands

Cash and Equivalents

Other Current Assets

Total Current Assets

Land & Improvements

Balance Sheet - Assets

Machinery, Furniture & Equipment

Other Fixed Assets

Total Fixed Assets

Gross Fixed Assets (Plant, Prop. & Equip.)

Net Fixed Assets (Net PP&E)

Other Non-Current Assets

Total Non-Current Assets

Other Current Liabilities

Total Current Liabilities

Deferred Income Taxes

Other Non-Current Liabilities

Total Non-Current Liabilities

Common Stock Equity

Additional Paid In Capital

Other Equity Adjustments

Total Liabilities & Stock Equity

Free Cash Flow

Accumulated Depreciation & Depletion

Balance Sheet - Liabilities, Stockholders Equity

Long Term Debt

Cumulative Translation Adjustment

Balance sheet of Johnson & Johnson company:

All numbers in thousands

Cash and Equivalents

Current Deferred Income Taxes